Ionis Pharmaceuticals(IONS) Stock Price Today

US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist

29.810
+0.070+0.24%

Close Apr 29 16:00 ET

27.100
-2.710-9.09%

Pre 04:00 ET

4.74BMarket Cap-9.81P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here's the Major Earnings Before the Open Tomorrow
Seeking Alpha18:00 ET
Ionis Pharmaceuticals Q1 2025 Earnings Preview
Seeking Alpha13:11 ET
New Harris Poll Findings Reveal HAE Patients Are Unsatisfied With Current Prophylactic Treatment Options, With Over 90% Interested in Trying New Therapies
BusinesswireApr 29 07:00 ET
Earnings Preview: IONS to Report Financial Results on April 30
Moomoo NewsApr 24 21:00 ET
Press Release: Ionis to Hold First Quarter 2025 Financial Results Webcast
Dow JonesApr 16 07:08 ET
Express News | Ionis Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $54 From $55
ReutersApr 16 06:11 ET

Comments

Teddy123

Apr 16 19:12

IonQ Signs MoU with Intellian, Deepening Its Commitment to Advancing South Korea’s Quantum Economy

$Ionis Pharmaceuticals (IONS.US)$
IonQ Takes Quantum Computing to Space: New Satellite Tech Partnership Expands Korean Presence

Teddy123

Mar 12 10:52

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera

$Ionis Pharmaceuticals (IONS.US)$
Massive $940M Deal: Ionis Partners with Ono on Breakthrough Blood Cancer Treatment

Teddy123

Mar 10 19:21

WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

$Ionis Pharmaceuticals (IONS.US)$
WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

The conservative Man

Dec 20, 2024 22:46

$Ionis Pharmaceuticals (IONS.US)$ got a good FDA approval and it’s going down crazy 😎

Meltyy

Dec 17, 2024 15:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...

IONS Ionis Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Earnings Season Underway